Jens Hillengass, MD
JENS HILLENGASS, MD, has been announced as the new Chief of Myeloma of the Roswell Park Comprehensive Cancer Center. As part of his new role, Dr. Hillengass will continue his research on hematologic diseases, including multiple myeloma and its precursor diseases.
A scientist with more than 15 years of experience, Dr. Hillengass also specializes in diagnostics and treatment of monoclonal plasma cell disorders, autologous stem cell transplantation, and hemato-oncologic imaging. His special interests include the early detection and characterization of monoclonal plasma cell disorders as well as imaging of bone or bone marrow involvement in monoclonal plasma cell diseases. ■
